서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 8 of 8

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2007-11	Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives Kim, Toe-You; Han, Soe-Won; Bang, Yung-Jue Expert Review of Molecular Diagnostics, Vol.7 No.6, pp.821-836	DOI
2014-02	FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study Su, X.; Zhan, P.; Gavine, P. R.; Morgan, S.; Womack, C.; Ni, X.; Shen, D.; Bang, Y-J; Im, S-A; Kim, W. Ho; Jung, E-J; Grabsch, H. I.; Kilgour, E. British Journal of Cancer, Vol.110 No.4, pp.967-975	DOI
2014-04	Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling Lee, Jin-Ku; Joo, Kyeung Min; Lee, Jeongwu; Yoon, Yeup; Nam, Do-Hyun OncoTargets and Therapy, Vol.7, pp.1933-1944	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2018-01	Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities Jung, Byung-Jin; Yoo, Hwan-Sic; Shin, Sooyoung; Park, Young-Joon; Jeon, Sang-Min Biomolecules & Therapeutics, Vol.26 No.1, pp.57-68	DOI
2019-10	The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab Shin, Jung Won; Kim, Soohyun; Ha, Suji; Choi, Byungsan; Kim, Seongyeong; Im, Seock-Ah; Yoon, Tae-Young; Chung, Junho Biomolecules, Vol.9 No.10, p. 629	DOI
2019-11	Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11) Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Kim, Jee Hyun; Kim, Tae-Yong; Jung, Kyung Hae; Park, Yeon Hee Breast Cancer Research and Treatment, Vol.178 No.2, pp.367-377	DOI
2022-06	Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors Mekonnen, Negesse; Yang, Hobin; Shin, Young Kee Frontiers in Oncology, Vol.12, p. 880643	DOI

1